Epzicom (Abacavir/3TC, Kivexa)
| Brand Name: |
Epzicom |
| Generic Name: |
Abacavir/Lamivudine, ABC/3TC |
| Adult Single Dose: |
One tablet containing 600 mg ABC and 300 mg 3TC (once a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NRTI |
|
|
|
- Epzicom/Kivexa (Abacavir + Lamivudine) (November 29, 2012)
To read PDF, click here.
From AIDS InfoNet
- An Overview of Epzicom (Abacavir/3TC, Kivexa) (September 13, 2012)
From AIDSinfo
- Epzicom (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FAQs About Epzicom (Abacavir/3TC, Kivexa) (January 1, 2012)
From The Body's "Ask the Experts" Forums
- Patient Information About Epzicom (Abacavir/3TC, Kivexa) (PDF) (November 2011)
From ViiV Healthcare
- Switch to HIV Combo Pill May Improve Lipids (September 15, 2010)
From MedPage Today
- Lipids Drop After Switch From ABC/3TC/Efavirenz to Atripla (September 15, 2010)
From National AIDS Treatment Advocacy Project
- ACTG 5202: Four Drugs Enter (March 8, 2010)
Part of a CROI 2010 wrap-up discussion with Joel Gallant, M.D., M.P.H.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- ACTG 5202: No Significant Difference in Time to Failure Between Kivexa and Truvada in Patients With Lower Viral Loads When Paired With Efavirenz or Atazanavir (February 18, 2010)
From aidsmap.com
- Serious Non-AIDS Health Problems (Especially Heart Problems) Appear Less Likely With Truvada Than Epzicom, But Low Bone Mineral Density Is More Likely, Switch Study Finds (October 20, 2009)
In Clinical Infectious Diseases
VIEW ALL ARTICLES
|
|
Advertisement
|